ATE293953T1 - Alpha-interferon enthaltende hautpflegemittel - Google Patents

Alpha-interferon enthaltende hautpflegemittel

Info

Publication number
ATE293953T1
ATE293953T1 AT01308850T AT01308850T ATE293953T1 AT E293953 T1 ATE293953 T1 AT E293953T1 AT 01308850 T AT01308850 T AT 01308850T AT 01308850 T AT01308850 T AT 01308850T AT E293953 T1 ATE293953 T1 AT E293953T1
Authority
AT
Austria
Prior art keywords
alpha interferon
containing alpha
products containing
skincare products
skincare
Prior art date
Application number
AT01308850T
Other languages
English (en)
Inventor
Jan Marini
Original Assignee
Jan Marini Skin Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jan Marini Skin Res Inc filed Critical Jan Marini Skin Res Inc
Application granted granted Critical
Publication of ATE293953T1 publication Critical patent/ATE293953T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01308850T 2000-11-03 2001-10-18 Alpha-interferon enthaltende hautpflegemittel ATE293953T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/705,319 US6328987B1 (en) 2000-11-03 2000-11-03 Cosmetic skin care compositions containing alpha interferon

Publications (1)

Publication Number Publication Date
ATE293953T1 true ATE293953T1 (de) 2005-05-15

Family

ID=24832930

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01308850T ATE293953T1 (de) 2000-11-03 2001-10-18 Alpha-interferon enthaltende hautpflegemittel

Country Status (4)

Country Link
US (1) US6328987B1 (de)
EP (1) EP1203579B1 (de)
AT (1) ATE293953T1 (de)
DE (1) DE60110342T8 (de)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1434561A1 (de) * 2001-10-05 2004-07-07 Procyte Corporation Peptid-kupferkomplexe und retinol, retinolderivate oder deren mischungen enthaltende hautpflegemittel
CA2462909A1 (en) * 2001-10-05 2003-06-12 Procyte Corporation Methods for the treatment of hyperpigmentation of skin
US6821524B2 (en) 2002-06-03 2004-11-23 Jan Marini Skin Research, Inc. Cosmetic skin care compositions
US20040038864A1 (en) * 2002-06-27 2004-02-26 Per Balschmidt Use of dimethyl sulfone as isotonicity agent
US20060166879A1 (en) * 2002-12-20 2006-07-27 Chakshu Research Inc Treatment of conditions associated with the presence of macromolecular aggregates, particularly ophthalmic disorders
US20060172972A1 (en) * 2002-12-20 2006-08-03 Chakshu Research Inc Formulation and method for administration of ophthalmologically active agents
US7014842B2 (en) * 2003-05-29 2006-03-21 Playtex Products, Inc. Sunscreen composition
HRPK20050965B3 (hr) * 2003-05-30 2007-11-30 De Paoli Ambrosi Gianfranco Kozmetički i/ili farmaceutski sastavi koji sadržedimetil sulfon za liječenje i prevenciju iritacija, upala i kožnih eritema
US20050226827A1 (en) * 2004-04-09 2005-10-13 Thienna Ho Skin lightening composition
WO2006004787A1 (en) * 2004-06-28 2006-01-12 Procyte Corporation Methods and compositions for preventing and treating hyperpigmentation of skin
US20060040002A1 (en) * 2004-08-17 2006-02-23 Boitano Suzanne M Anti-itch composition
CA2598792A1 (en) 2005-03-02 2006-09-08 Metanomics Gmbh Process for the production of fine chemicals
US20060293228A1 (en) * 2005-06-24 2006-12-28 Bhatnagar Rajendra S Therapeutic compositions and methods using transforming growth factor-beta mimics
US20060293227A1 (en) * 2005-06-24 2006-12-28 Bhatnagar Rajendra S Cosmetic compositions and methods using transforming growth factor-beta mimics
US20070166266A1 (en) * 2006-01-19 2007-07-19 Solazyme, Inc. Methods and compositions for improving the health and appearance of skin
US8298548B2 (en) 2007-07-18 2012-10-30 Solazyme, Inc. Compositions for improving the health and appearance of skin
US8277849B2 (en) 2006-01-19 2012-10-02 Solazyme, Inc. Microalgae-derived compositions for improving the health and appearance of skin
US20090274736A1 (en) * 2006-01-19 2009-11-05 Solazyme Inc. Nutraceutical Compositions From Microalgae And Related Methods of Production And Administration
US8435547B2 (en) * 2006-08-30 2013-05-07 John P. Blass Cream for stimulating mitochondrial activity in the skin
US8927522B2 (en) 2008-10-14 2015-01-06 Solazyme, Inc. Microalgal polysaccharide compositions
US8557249B2 (en) 2008-11-07 2013-10-15 Solazyme, Inc. Cosmetic compositions comprising microalgal components
US20100247693A1 (en) * 2009-03-24 2010-09-30 Marini Jan L Cosmetic formulation to treat rosacea telangiectasia
JP5651186B2 (ja) * 2009-10-30 2015-01-07 バイオジェニック イノベーションズ， リミテッド ライアビリティ カンパニー 薬剤耐性微生物を処置するためのメチルスルホニルメタン（ｍｓｍ）
US9839609B2 (en) 2009-10-30 2017-12-12 Abela Pharmaceuticals, Inc. Dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) formulations to treat osteoarthritis
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
ES2885523T3 (es) 2011-11-23 2021-12-14 Therapeuticsmd Inc Formulaciones y terapias de reposición hormonal de combinación naturales
US10471131B2 (en) 2012-01-19 2019-11-12 Hybrid Medical, Llc Topical therapeutic formulations
US9333242B2 (en) 2012-01-19 2016-05-10 Hybrid Medical, Llc Topical therapeutic formulations
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9808654B2 (en) 2013-02-11 2017-11-07 Jan Marini Skin Research Post procedure skin care gel and methods of use thereof
US9597280B2 (en) 2013-05-15 2017-03-21 Terravia Holdings, Inc. Cosmetic compositions comprising microalgal oil
MX2016014281A (es) 2014-05-22 2017-02-22 Therapeuticsmd Inc Formulaciones y terapias de reemplazo de combinación de hormonas naturales.
DE202015008361U1 (de) 2014-12-03 2016-04-21 Mary Kay Inc. Kosmetische Zusammensetzungen
US9572767B2 (en) 2015-05-20 2017-02-21 Jan Marini Skin Research Luminate hand cream
US10034825B2 (en) 2015-07-01 2018-07-31 Jan Marini Skin Research Luminate eye gel
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
KR20250006343A (ko) 2015-07-27 2025-01-10 마리 케이 인코포레이티드 국소 피부 제형들
EP4289412A3 (de) 2015-07-28 2024-03-06 Mary Kay, Inc. Topische hautformulierungen
US9949913B2 (en) 2016-03-14 2018-04-24 Jan Marini Skin Research Luminate face lotion
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
AU2017239645A1 (en) 2016-04-01 2018-10-18 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10596090B2 (en) 2016-05-27 2020-03-24 Jan Marini Skin Research Cosmetic formulation to reduce facial flushing
US10610479B2 (en) 2017-08-07 2020-04-07 Jan Marini Skin Research HYLA3D hyaluronic acid activating lip complex
US10179103B1 (en) 2018-05-16 2019-01-15 Jan Marini Skin Research Anti-cellulite cream
WO2021119664A1 (en) 2019-12-10 2021-06-17 Mary Kay Inc. Herbal cosmetic composition for treating skin
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4957734A (en) * 1982-06-14 1990-09-18 Exovir, Inc. Treatment of certain skin malignancies and pre-malignant skin lesions, herpes zoster and psoriasis
US4469228A (en) * 1983-05-31 1984-09-04 Schering Corporation Interferon kit
US4800081A (en) * 1984-04-18 1989-01-24 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
DE3603444A1 (de) * 1986-02-05 1987-08-06 Thomae Gmbh Dr K Pharmazeutische zubereitungsformen zur stabilisierung von interferon alpha
US5686489A (en) * 1986-12-23 1997-11-11 Tristrata Technology, Inc. Alpha hydroxyacid esters for skin aging
US5165921A (en) * 1989-01-23 1992-11-24 National Geno Sciences, Inc. Method for treating condyloma acuminatum with interferon
US5968989A (en) * 1991-12-18 1999-10-19 The Salk Institute For Biological Studies Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
US5853755A (en) 1993-07-28 1998-12-29 Pharmaderm Laboratories Ltd. Biphasic multilamellar lipid vesicles
HUP9602024A3 (en) * 1996-07-25 1999-05-28 Toth Sandor Pharmaceutical composition containing aminoacid for external use

Also Published As

Publication number Publication date
DE60110342T2 (de) 2006-01-26
DE60110342D1 (de) 2005-06-02
DE60110342T8 (de) 2006-08-24
EP1203579B1 (de) 2005-04-27
EP1203579A1 (de) 2002-05-08
US6328987B1 (en) 2001-12-11

Similar Documents

Publication Publication Date Title
ATE293953T1 (de) Alpha-interferon enthaltende hautpflegemittel
ATE365534T1 (de) Kosmetische hautpflegezusammensetzungen
ES2162268T3 (es) Composiciones cosmeticas a base de pirazolin-4,5-dionas, nuevas pirazolin-4,5-dionas, procedimientos de preparacion y utilizaciones.
ATE262313T1 (de) Kosmetisches mittel enthaltend maulbeerbaumextrakt und retinoide
ES2243801T3 (es) Equivalente de piel/cabello con papilas reconstruidas.
MX212986B (es) Composiciones cosmetica para mantener fija la forma del cabello y dar apariencia brollosa al mismo.
WO2004012650A3 (fr) Compositions cosmetiques ou dermopharmaceutiques comprenant du kombucha.
DE59410330D1 (de) Ectoin und Ectoinderivate als Feuchtigkeitsspender in Kosmetikprodukten
ES2149329T3 (es) Composiciones cosmeticas detergentes y utilizaciones.
MX9201990A (es) Composiciones cosmeticas en forma de gel, transparentes, substancialmente anhidras y barras desodorantes y antitranspirantes que las contienen.
BR0300830A (pt) Composições tópicas anticâncer e métodos de uso destas
AU3227700A (en) Skin sanitizing compositions
ATE477789T1 (de) Zubereitungen die lotusextrakte und methyldonatoren enthalten
DE69918382D1 (de) Turmalin enthaltende kosmetische reinigungszusammensetzung
AR009763A1 (es) Utilizacion en una composicion como estimulador de tirosinasa de al menos un derivado de 3-oxido pirimidina, sustituido en la posicin 6
ES2167852T3 (es) Utilizacion de derivados oxamato como agentes despigmentantes.
ITMI20011022A0 (it) Composizioni farmaceutiche e cosmetiche contro l'invecchiamento cutaneo
MXPA02004934A (es) Composiciones cosmeticas conteniendo extracto de anis y retinoides.
NO964238D0 (no) Halofantrin-fri-base for behandling av malaria og blandinger
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
FR2810540B1 (fr) Nouvelles preparations cosmetiques ou hygieniques sous forme de dispersion
AR027898A1 (es) Composiciones cosmeticas y metodos para aclarar la piel
ES2072230A1 (es) Composicion cosmetica y metodo de tratamiento estetico que se opone al envejecimiento de la piel.
DE60235132D1 (de) Sojaprodukte enthaltende Zusammensetzungen
ATE369185T1 (de) Riechstoffmischungen mit gesteigerter geruchstärke

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties